Table 1.

Patient Baseline Characteristics.

Patient Characteristic (n=175 patients; 176 diagnoses)	Number of patients (%)
Age at diagnosis (mean, range)	63 years, 27–87 years
Gender
Male	86 (49.1%)
Female	89 (50.9%)
Ashkenazi Jewish (AJ) ancestry	98 (56.0%)
Pathology
Adenocarcinoma NOS	171 (97.7%)
Acinar	2 (1.1%)
Mixed (neuroendocrine, acinar, and ductal/adenocarcinoma features)	3 (1.7%)
Personal Cancer History
>1 Primary cancer	46 (26.3%)
Breast	16 (9.1%)
Prostate	14 (8.0%)
Melanoma	9 (5.1%)
Urinary tract (bladder, renal)	4 (2.3%)
Metachronous pancreas cancer	1 (0.6%)
Other	10 (5.7%)
Family History
FDR and/or SDR with breast cancer:
0	89 (50.9%)
1	57 (32.6)
2	22 (12.6%)
≥3	7 (4.0%)
FDR and/or SDR with ovarian cancer:
0	150 (85.7%)
1	24 (13.7%)
2	1 (0.6%)
≥3	0 (0.0%)
FDR and/or SDR with colorectal cancer:
0	127 (72.6%)
1	38 (21.7%)
2	3 (1.7%)
≥3	7 (4.0%)
FDR and/or SDR with pancreatic cancer:
0	114 (65.1%)
1	50 (28.6%)
2	11 (6.3%)
≥3	0 (0.0%)
Familial Pancreatic cancer (PC in ≥2 FDRs including proband):	40 (22.9%)

FDR = first degree relative; SDR = second degree relative; PC = pancreatic cancer